MYOPEPDYS

WIPO WIPO 2022

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark MYOPEPDYS was filed as Word mark on 10/12/2022 at the World Intellectual Property Organization.

Trademark Details Last update: August 14, 2023

Trademark form Word mark
File reference 1696907
Countries Brazil Canada Switzerland China United Kingdom India Iceland Japan South Korea Mexico Norway Russia Turkey
Base trademark US No. 97368285, April 18, 2022
Application date October 12, 2022
Expiration date October 12, 2032

Trademark owner

215 First Street
Cambridge MA 02142
US

Trademark representatives

3724 Benson Drive Raleigh NC 27609 US

goods and services

05 Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; pharmaceutical preparations that modulate rna expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; gene therapy products, namely, gene delivery pharmaceuticals; pharmaceutical preparations for gene therapy, gene editing, and genome editing; gene therapy products in the nature of pharmaceuticals for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; viruses, viral vectors and viral constructs for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases

Trademark history

Date Document number Area Entry
July 19, 2023 2023/29 Gaz TR Rejection
April 24, 2023 2023/17 Gaz GB Rejection
February 27, 2023 2023/9 Gaz RU Rejection
October 12, 2022 2022/44 Gaz US Registration

ID: 141696907